One of the unique aspects of the bacterial cell wall is the presence of D-amino acids in the peptidoglycan. The D-amino acids confer several essential properties on the peptidoglycan, including conformation and resistance to proteases. For the D-alanine moiety, the pathway for biosynthesis is well characterized (3, 33) . Likewise, the mesodiaminopimelic acid biosynthetic scheme and its relation to lysine biosynthesis is known (4) . However, understanding of the route of D-glutamic acid biosynthesis has been relatively sparse, with very little information available concerning D-glutamate in enteric bacteria, such as Escherichia coli.
Early studies investigated D-glutamate biosynthesis in either Bacillus sp. and in lactobacilli and pediococci. In Bacillus sp., D-glutamate is formed by a D-amino acid transaminase utilizing D-alanine and a-ketoglutarate (15, (29) (30) (31) . In contrast, Lactobacillus sp. and Pediococcus sp. apparently use a racemase that converts L-glutamate to D-glutamate (21, 22) . Thus, at least two different biosynthetic routes for D-glutamate are known in bacteria. In E. coli, the overall glutamic acid pool is high, and approximately 10% of the pool is in the form of D-glutamic acid (18) . Nevertheless, attempts to define the enzymatic mechanism for D-glutamate synthesis in E. co0i have all met with failure to date (8, 21, 22, 29) . In an attempt to clarify the situation in E. coli, we initiated investigation of the genes involved in D-glutamate biosynthesis. Only one D-glutamate auxotrophic mutant in E. coli has been reported to date. The mutation in E. coli B/r WM335, which renders the bacteria absolutely dependent on an exogeneous source of D-glutamate, has been mapped to the 70-to 90-min region on the E. coli chromosome (17) . In the present study, we refine the map position to 89.8 min. The mutation was found to reside in a previously reported unidentified open reading frame (2) . Upon further investigation, it was found that the D-glutamic acid mutant strain E. coil B/r WM335 is a double mutant, with an additional mutation in a glutamate transport gene at 82 min on the map. Construction of viable D-glutamic acid auxotrophs requires that both mutations be present. * (27) . The mini-TnlO was from E. coli GE1031 (supE42 Fzzf-1831::TnlOdtet), and the transposase was in strain GE886(pNK972). Both strains were obtained from Cold Spring Harbor Laboratory. The Hfr donor strains used for mapping were an Hfr mapping kit, with known origins of transfer, obtained from B. Bachmann (E. coli Genetic Stock Center, Yale University, New Haven, Conn.). The lowcopy-number plasmid pCL1920 was kindly provided by C. Lerner (16) . The Kohara ordered X bacteriophage bank (14) was a gift from Y. Kohara. Bacteria were routinely grown overnight in tryptone broth (TB) (supplemented with 200 pg of thymidine per ml and 100 pg of D-glutamate per ml for strain WM335) at 30'C with aeration. A 1:100 dilution of the overnight culture was made into Lennox L broth (LB; GIBCO BRL, Gaithersburg, Md.), with supplementation as above. Bacteria were also cultured in M9 minimal media (GIBCO BRL) with 0.2% glucose. Growth was at 370C with aeration. Antibiotics (Sigma Chemical Co., St. Louis, Mo.) were added as follows: ampicillin (25 pg/ml), tetracycline (10 pg/ml), chloramphenicol (25 ,ug/ml), D-cycloserine (50 pg/ ml), and spectinomycin (50 ,ug/ml).
Bacterial conjugation, transformation, and transduction.
Bacterial conjugations were performed in liquid media essentially as described by Miller (19) . Because of the known stability problems, colonies of the Hfr donor strains were tested by patching onto a lawn of appropriately marked Frecipients, to select cells with a chromosomally integrated F factor (19 (27) .
Recombinant DNA procedures. Procedures for the preparation of X phage DNA, bacterial chromosomal DNA, and plasmids were performed by standard methods (24) . Restric (25) . The Sequenase 2.0 kit was used according to the manufacturer's protocol (United States Biochemical Corp., Cleveland, Ohio). Starting primers were universal and reverse primers of pUC18, continuing with internal sequence-specific primers. DNA sequencing information was analyzed with the GENEPRO computer program, version 5.0 (Riverside Scientific Enterprises, Bainbridge, Wash.), using the GenBank release 71 data base.
Plasmid-directed protein synthesis. Plasmid DNA was transformed into the minicell-producing strain M1241. Minicells were isolated, and [35Slmethionine (1, 232 Ci/mmol; DuPont, NEN Research Products, Boston, Mass.) was used to label newly synthesized plasmid-encoded proteins (13). This was followed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and autoradiography, as previously described (23) .
RESULTS
Hfr mapping studies. As an initial approach to mapping the D-glutamate mutation in E. coli WM335, a collection of Hfr strains with known origins of transfer were mated with WM335 containing a TnlO transposon, with selection for tetracycline resistance and D-glutamate independence. The matings confirmed that the D-glutamate-requiring mutation was in the previously reported region (17) . Further studies of interrupted matings between Hfr strain KL800 (origin of a Strains are the P1 mapping set described by Singer et al. (27) . The P1 phage was propagated on these strains and subsequently used to transduce E. coli WM335.
b Map positions are the approximate points of transposon insertion on the standard E. coli genetic map.
c Selection was initially for tetracycline resistance or kanamycin resistance, depending on the transposon, followed by scoring for D-glutamate independence.
transfer at 76 min), Hfr strain Ra-2 (origin of transfer at 87 min), and WM335 Tetr, as the recipient indicated that the D-glutamate mutation was in the 90-min region (data not shown). This information was used to define appropriate P1 phage transduction crosses for fine structure mapping of the gene location. P1 transductional studies. Earlier studies (20) indicated that a potential cluster of peptidoglycan biosynthesis genes mapped in the 90-min region of the E. coli chromosome. With the Hfr data indicating that the D-glutamate mutation could be in the region, we elected to begin P1 phage transductional studies around 90 min. A set of strains (D-glutamate positive) with known transposon insertions (27) were used to propagate a series of P1-transducing lysates that were crossed with strain WM335. Primary selection was for antibiotic resistance, with subsequent determination of D-glutamate dependency. As evidenced in Table 1 (14) into the HindIII restriction site of pCL1920 (16) . Plasmid pRDD018 was derived by subcloning the 1.7-kb EcoRV-HindIII fragment containing the dga gene from pRDD017 into the EcoRV-HindIII restriction sites of plasmid pACYC184 (24) . Plasmid pRDD019 was constructed by subcloning the 1.3-kb DraI-EcoRV fragment from pRDD018 into pACYC184. Plasmid pRDD020 was constructed by subcloning the 1.3-kb DraI-EcoRV fragment from pRDD018 into pUC18. P1 Using the transductional data, phages from the Kohara ordered X bank were used as a source of DNA from the region. DNA from several phages that covered over 70 kb in the 90-min region was prepared. The DNA from the phages was cloned into a low-copy-number vector, pCL1920, and a 3.0-kb fragment was found that complemented WM335 (Fig.   1, pRDD017) . DNA sequencing of the region revealed a known gene, btuB, and a previously reported open reading frame (2) at 89.8 min (GenBank accession number V00348) that consisted of 867 bp (Fig. 2) . We designated this gene dga (for D-glutamic acid). Subsequent cloning experiments eliminated most of the btuB region and revealed that removal of two strong promoters, P1 and P2, just downstream of dga allowed the dga region to be tolerated on the high-copynumber vector pUC18 (Fig. 1, pRDD020 ). Plasmid pRDD019 (Fig. 1) , pACYC184 with the dga coding region, was used in minicells, and analysis of plasmid-encoded proteins revealed a protein of the expected 30-kDa size (Fig. 3 ). All the above plasmids complemented the D-glutamate requirement of E. coli WM335.
To determine the genetic lesion in the dga gene responsi- (Fig. 4) resistance marker was used to transduce this region into E. coli K-12. Several of these transductants were then used in a second round of transduction in which the D-glutamate auxotrophic characteristic at 90 min from WM335 was introduced. Using this strategy, it was now possible to recover D-glutamate auxotrophs in E. coli K-12, as well as in E. coli B/r ATCC 12407 (data not shown).
Cloning and sequencing of giS gene of E. coli WM335. As described above, introduction of the gltS region from E. coli WM335 into E. coli K-12 was apparently essential to obtain subsequent D-glutamate auxotrophs. This implied that the gltS gene of strain WM335 contained a mutation. The gltS gene from E. coli WM335 was cloned by using SalI-digested genomic DNA and ligation into pUC18. The clone containing the gltS gene was selected in K-12 by growth on M9 minimal medium with glutamate as the sole carbon and nitrogen source (6) . A candidate plasmid with a 7.1-kb insert was found to contain the gltS region (pRDD021, Fig. 5 ). DNA sequence analysis of this plasmid revealed that there were two changes from the previously reported wild-type gltS sequence of E. coli B (6) (GenBank accession number D00626). As shown in Fig. 6 , the mutations both resulted in substitutions for alanine residues. We could not construct a D-glutamate-requiring mutant with the mutated copy of the gltS from WM335 present in trans on a plasmid. However, introduction of the linearized plasmid into the chromosome of the recBC strain JC7623 via homologous recombination essential amino acid present in the peptide side chain of the N-acetylmuramic acid of the peptidoglycan (3, 11) . Surprisingly little is known concerning the biosynthesis of D-glutamic acid in medically important bacteria (21, 22, 29) . In E. coli, the enzymatic mechanism remains unknown. Lugtenberg et al. (17) (23, 28) .
A second possibility was suggested by the fact that E. coli is known to be relatively poor at transporting D-glutamic acid intracellularly (1, 6, 32) . This raised the possibility that E. coli WM335 was in fact a double mutant, having a defect in the dga locus and an additional mutation in the transport locus that influenced the uptake of exogeneous D-glutamate. The most likely candidate of the three known D-glutamate transport systems was gUtS (1, 6, 12) . When the gltS gene of E. coli WM335 was linked to a transposon and transduced into E. coli K-12, it was then possible to subsequently introduce the dga locus from WM335 and obtain a D-glutamate-requiring E. coli K-12. Presumably, without the gUtS locus from strain WM335, introduction of dga into E. coli K-12 leads to cell death due to low intracellular levels of D-glutamate, despite the fact that the external medium contains high concentrations of this essential peptidoglycan component. Subsequent cloning of the gltS gene from E. coli WM335 revealed two changes in the amino acid sequence from the wild-type gene found in E. coli B (7). We hypothesize that the gltS mutations allow cells to be subsequently transduced to D-glutamate auxotrophy by affecting D-glutamate uptake from the external medium. Introduction of a linear fragment (ca. 6.0 kb) containing the gltS gene from WM335 into E. coli JC7623, which is capable of integrating linear DNA, led to the isolation of D-glutamate requirers after subsequent P1 transduction of the mutant dga locus. Thus, it is very likely that one or both changes observed in the gltS permease gene from strain WM335 are responsible for its role in the D-glutamate-requiring strains. Note that it is essential to introduce the mutated gltS before the mutated dga in construction of D-glutamate auxotrophs.
The demonstration that transduction of two genes, the mutated gltS and the mutated dga, are necessary and sufficient for the construction of D-glutamate-requiring mutants argues against another biosynthetic mutation being present. If a second biosynthetic mutation was present, it would have to be located close to dga, since phage transduction of this region from WM335 yields a D-glutamate-requiring phenotype, provided that the mutant form ofgltS is also present on the chromosomal DNA. A remote possibility is that a second D-glutamate biosynthetic gene resides close by gltS; however, it would need to be on the 6-kb fragment described above. Recent work by Kalman et al. (12) had partially characterized the region immediately surrounding gltS, and no unidentified open reading frames were reported.
Still unresolved is the biochemical mechanism of D-glutamate biosynthesis in E. coli. The genetic information and tools developed in the present study will undoubtedly contribute to further advancement of the problem. Also to be addressed is the biochemical alteration in the mutant form of gltS that permits the isolation of D-glutamate auxotrophs. Transport studies with radiolabelled D-glutamate will be necessary to clarify this issue. Clearly, if our studies are correct, the initial isolation of E. coli WM335 was very fortuitous and explains why it is the only reported D-glutamate-requiring mutant to date.
